Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation
CU Meyer, P Habermehl, M Knuf, B Hoet… - Human …, 2008 - Taylor & Francis
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation
CU Meyer, P Habermehl, M Knuf, B Hoet, J Wolter… - 2008 - pubmed.ncbi.nlm.nih.gov
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
[PDF][PDF] Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children
CU Meyer, P Habermehl, M Knuf, B Hoet, J Wolter… - Human …, 2008 - academia.edu
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4–6 years was evaluated. Immunogenicity and CMI …
vaccine in DTPa-primed children aged 4–6 years was evaluated. Immunogenicity and CMI …
Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation.
CU Meyer, P Habermehl, M Knuf, B Hoet, J Wolter… - Human …, 2008 - europepmc.org
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
[PDF][PDF] Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children
CU Meyer, P Habermehl, M Knuf, B Hoet… - Human …, 2008 - researchgate.net
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4–6 years was evaluated. Immunogenicity and CMI …
vaccine in DTPa-primed children aged 4–6 years was evaluated. Immunogenicity and CMI …
[PDF][PDF] Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children
CU Meyer, P Habermehl, M Knuf, B Hoet… - Human …, 2008 - researchgate.net
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4–6 years was evaluated. Immunogenicity and CMI …
vaccine in DTPa-primed children aged 4–6 years was evaluated. Immunogenicity and CMI …
[PDF][PDF] Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children
CU Meyer, P Habermehl, M Knuf, B Hoet, J Wolter… - Human …, 2008 - academia.edu
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4–6 years was evaluated. Immunogenicity and CMI …
vaccine in DTPa-primed children aged 4–6 years was evaluated. Immunogenicity and CMI …